Product Information

LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0621 per EA under NDC 59746033710. Its NADAC has been published 283 times since Jan 27, 2021.

The High Outlier badge above means this manufacturer's average price in the losartan potassium and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB

losartan potassium and hydrochlorothiazide
$0.0621per EA
High Outlier

Strength

12.5; 50 mg/1; mg/1

NDC

59746033710

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201845

On Market Since

10/30/2012

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has been published 283 times since Jan 27, 2021, and over the history we have for it it has declined 62.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0621 per EA
All-time high$0.1848 (Apr 13, 2022)
All-time low$0.0592 (Apr 22, 2026)
52-week high$0.0797
52-week low$0.0592
Median price$0.0990
Average price$0.1093
Largest weekly change-22.4% (Nov 20, 2024)
Weeks tracked283
Tracking sinceJan 27, 2021

Price History

1W

0.0%

1M

+0.5%

3M

-3.9%

6M

-18.4%

1Y

-20.9%

3Y

-37.2%

5Y

-61.0%

All

-62.1%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0621 per EA (NDC 59746033710), effective Jun 24, 2026.

How has the price of LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has declined 62.1%. It has been tracked across 283 weekly CMS publications since Jan 27, 2021.

What are the highest and lowest recorded NADAC prices for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

Since Jan 27, 2021, the NADAC for LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB has ranged from a low of $0.0592 (Apr 22, 2026) to a high of $0.1848 (Apr 13, 2022), with a median of $0.0990 per EA.

Are there cheaper alternatives to LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

4 NADAC-published products share the same active ingredient, strength, and dosage form as LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB, but none are currently priced below it.

Who manufactures LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB?

LOSARTAN-HYDROCHLOROTHIAZIDE 50-12.5 MG TAB (NDC 59746033710) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.